These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35270562)

  • 1. Genetic Diversity of Antimicrobial Resistance and Key Virulence Features in Two Extensively Drug-Resistant
    Marazzato M; Scribano D; Sarshar M; Brunetti F; Fillo S; Fortunato A; Lista F; Palamara AT; Zagaglia C; Ambrosi C
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic epidemiology of severe community-onset Acinetobacter baumannii infection.
    Meumann EM; Anstey NM; Currie BJ; Piera KA; Kenyon JJ; Hall RM; Davis JS; Sarovich DS
    Microb Genom; 2019 Mar; 5(3):. PubMed ID: 30806611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.
    Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H
    Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
    Jalal D; Elzayat MG; Diab AA; El-Shqanqery HE; Samir O; Bakry U; Hassan R; Elanany M; Shalaby L; Sayed AA
    mSphere; 2021 Dec; 6(6):e0072521. PubMed ID: 34787450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.
    Bahador A; Farshadzadeh Z; Raoofian R; Mokhtaran M; Pourakbari B; Pourhajibagher M; Hashemi FB
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):24. PubMed ID: 29859115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam.
    Wareth G; Linde J; Hammer P; Nguyen NH; Nguyen TNM; Splettstoesser WD; Makarewicz O; Neubauer H; Sprague LD; Pletz MW
    Int J Antimicrob Agents; 2020 Oct; 56(4):106127. PubMed ID: 32750418
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Nodari CS; Fuchs SA; Xanthopoulou K; Cayô R; Seifert H; Gales AC; Dilthey A; Higgins PG
    mSphere; 2021 Dec; 6(6):e0074621. PubMed ID: 34851165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole Genome Analysis of Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates in Thailand.
    Chopjitt P; Kerdsin A; Takeuchi D; Hatrongjit R; Boueroy P; Akeda Y; Tomono K; Hamada S
    Infect Disord Drug Targets; 2021; 21(5):e270421188042. PubMed ID: 33200701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic Characterization and Heterogeneity among Modern Clinical Isolates of Acinetobacter baumannii.
    Valcek A; Philippe C; Whiteway C; Robino E; Nesporova K; Bové M; Coenye T; De Pooter T; De Coster W; Strazisar M; Van der Henst C
    Microbiol Spectr; 2023 Feb; 11(1):e0306122. PubMed ID: 36475894
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Dahdouh E; Hajjar M; Suarez M; Daoud Z
    Front Cell Infect Microbiol; 2016; 6():163. PubMed ID: 27933276
    [No Abstract]   [Full Text] [Related]  

  • 12. Genomic and phenotypic analyses of diverse non-clinical
    Hamidian M; Maharjan RP; Farrugia DN; Delgado NN; Dinh H; Short FL; Kostoulias X; Peleg AY; Paulsen IT; Cain AK
    Microb Genom; 2022 Feb; 8(2):. PubMed ID: 35166651
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.
    Trebosc V; Gartenmann S; Royet K; Manfredi P; Tötzl M; Schellhorn B; Pieren M; Tigges M; Lociuro S; Sennhenn PC; Gitzinger M; Bumann D; Kemmer C
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7263-7271. PubMed ID: 27671072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of target site mutations and plasmid associated resistance genes acquisition on resistance of Acinetobacter baumannii to fluoroquinolones.
    Mohammed MA; Salim MTA; Anwer BE; Aboshanab KM; Aboulwafa MM
    Sci Rep; 2021 Oct; 11(1):20136. PubMed ID: 34635692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acinetobacter baumannii NCIMB8209: a Rare Environmental Strain Displaying Extensive Insertion Sequence-Mediated Genome Remodeling Resulting in the Loss of Exposed Cell Structures and Defensive Mechanisms.
    Repizo GD; Espariz M; Seravalle JL; Díaz Miloslavich JI; Steimbrüch BA; Shuman HA; Viale AM
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32727858
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii.
    Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M
    Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic analysis of Acinetobacter baumannii clinical isolates reveals extensive genomic variation and diverse antibiotic resistance determinants.
    Liu F; Zhu Y; Yi Y; Lu N; Zhu B; Hu Y
    BMC Genomics; 2014 Dec; 15(1):1163. PubMed ID: 25534766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.